Sign up to save your podcasts
Or
Share Day 2: Top Takeaways From ASCO26
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Day 2: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer.
LINK TO FULL TRANSCRIPT
View all episodes
By American Society of Clinical Oncology (ASCO)
4.6
5656 ratings
Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer.
LINK TO FULL TRANSCRIPT
More shows like ASCO Daily News
View all
NEJM This Week
321 Listeners
JAMA Clinical Reviews
504 Listeners
Journal of Clinical Oncology (JCO) Podcast
39 Listeners
Breast Cancer Update
65 Listeners
Nature Podcast
756 Listeners
Research To Practice | Oncology Videos
121 Listeners
All Ears English Podcast
2,262 Listeners
Science Magazine Podcast
818 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
46 Listeners
ASCO Education
32 Listeners
Think Fast Talk Smart: Communication Techniques
828 Listeners
Oncology Today with Dr Neil Love
59 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
45 Listeners